Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Guinot

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Annales De L'Anesthesiologie Francaise|January 1, 1977
[Postoperative nitrogen balance in the elderly. Effects of an anti-aldosterone drug]P Guinot, Y Metivier
Pathologie-Biologie|October 14, 1998
[Antisense oligonucleotides: a new therapeutic approach]P Guinot, J Temsamani
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 1, 1979
[Development of an antihypertensive agent. Methodology and cost]J Duchier, P Guinot
Drugs Under Experimental and Clinical Research|January 1, 1988
Study of the effects of cicletanine on the renin-angiotensin-aldosterone systemH Bippi, P Guinot
Biotechnology and Applied Biochemistry|November 14, 1997
Antisense oligonucleotides: a new therapeutic approachJ Temsamani, P Guinot
Drugs Under Experimental and Clinical Research|January 1, 1988
Efficacy and tolerance of cicletanine, a new antihypertensive agent: overview of 1226 treated patientsT Tarrade, P Guinot
Arzneimittel-Forschung|January 1, 1985
Study of the effects of cicletanine on prostanoidsP Guinot, J C Frölich
Drugs Under Experimental and Clinical Research|January 1, 1988
Review of three studies to determine the efficacy and tolerance of cicletanine in the short- and long-term treatment of essential hypertensionG P Fodor, P Guinot
Expert Opinion on Investigational Drugs|July 5, 2005
Antisense approach for the treatment of cytomegalovirus infectionJ Temsamani, G S Pari, P Guinot
Arzneimittel-Forschung|January 1, 1989
Determination of the optimal dose of the antihypertensive drug cicletanine hydrochloride in manP Guinot, J Jewitt-Harris, T Tarrade
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Annales De L'Anesthesiologie Francaise|January 1, 1977
[Postoperative nitrogen balance in the elderly. Effects of an anti-aldosterone drug]P Guinot, Y Metivier
Pathologie-Biologie|October 14, 1998
[Antisense oligonucleotides: a new therapeutic approach]P Guinot, J Temsamani
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 1, 1979
[Development of an antihypertensive agent. Methodology and cost]J Duchier, P Guinot
Drugs Under Experimental and Clinical Research|January 1, 1988
Study of the effects of cicletanine on the renin-angiotensin-aldosterone systemH Bippi, P Guinot
Biotechnology and Applied Biochemistry|November 14, 1997
Antisense oligonucleotides: a new therapeutic approachJ Temsamani, P Guinot
Drugs Under Experimental and Clinical Research|January 1, 1988
Efficacy and tolerance of cicletanine, a new antihypertensive agent: overview of 1226 treated patientsT Tarrade, P Guinot
Arzneimittel-Forschung|January 1, 1985
Study of the effects of cicletanine on prostanoidsP Guinot, J C Frölich
Drugs Under Experimental and Clinical Research|January 1, 1988
Review of three studies to determine the efficacy and tolerance of cicletanine in the short- and long-term treatment of essential hypertensionG P Fodor, P Guinot
Expert Opinion on Investigational Drugs|July 5, 2005
Antisense approach for the treatment of cytomegalovirus infectionJ Temsamani, G S Pari, P Guinot
Arzneimittel-Forschung|January 1, 1989
Determination of the optimal dose of the antihypertensive drug cicletanine hydrochloride in manP Guinot, J Jewitt-Harris, T Tarrade
Pageof 3